Hepatitis C Therapy - Intercell announces preliminary 2005 full year results: Good ...

Intercell announces preliminary 2005 full year results: Good ...
news aktuell (Pressemitteilung), Germany - Mar 5, 2006... these results, Intercell is now planning to test IC41 with this optimized schedule in a further Phase II trial in patients with chronic Hepatitis C. This study ...

Nature Reviews Drug Discovery Writes On AVI BioPharma's NEUGENE ...
Trading Markets, CA - Mar 7, 2006... AVI is currently enrolling patients with chronic hepatitis C infection in a Phase I/II clinical trial in the US The company has also reported early success in ...

Nabi Biopharmaceuticals to Present at the Lehman Brothers Ninth ...
PR Newswire (press release), NY - Mar 3, 2006... to prevent hepatitis C disease in HCV-positive liver transplant patients and is being evaluated for the treatment of chronic hepatitis C virus infections. ...

Clinical Trial Results Show That Peregrine's First-In-Class Anti ...
International News Service, Australia - Feb 27, 2006... that its first-in-class anti-viral compound Tarvacin(TM) Anti-Viral appeared safe and well-tolerated in a Phase l study in chronic hepatitis C virus (HCV ...

MIGENIX Third Quarter Fiscal 2006 Financial Results Conference ...
PR Newswire (press release), NY - Mar 2, 2006... The Company's clinical programs include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter-related ...